BN Business News
Add your company to Business Communicator →

Regulation & law · 19/11/20261 min read

SGRY Shareholders: Amparo Law Firm PLLC Is Investigating Whether Surgery Partners's $23.50-Per-Share Sale to HealthSpan Partners Delivers the Best Value for Shareholders

EDITORIAL ILLUSTRATIONR&Regulation & lawBN
Illustration generated by Business News; it is not a source photograph.

Summary

Amparo Law Firm PLLC, through its Amparo Investor Rights practice, is investigating whether $23.50 per share is the best price Surgery Partners, Inc. (Nasdaq: SGRY) shareholders could obtain, whether the board ran a sale process designed to get it, and whether shareholders may have claims for...

Original source language: GlobeNewswire — Mergers and AcquisitionsOpen original release →

Explore insights

Business insights →